The primary trial data of the Phase III study AXIS 1032 was released in May 2010.
-
A micrograph showing cells in renal cell carcinoma present in the right side... -
Axitinib is an investigational drug being developed by Pfizer for treating... -
Pfizer submitted a new drug application for the treatment of advanced renal... -
The primary trial data of the Phase III study AXIS 1032 was released in May...